Characterization of CIA-1, an ambler class A extended-spectrum β-lactamase from Chryseobacterium indologenes

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 1, 2012, Pages 588-590

  Matsumoto, Takehisa ^a   Nagata, Mika ^b   Ishimine, Nau ^a   Kawasaki, Kenji ^a   Yamauchi, Kazuyoshi ^c   Hidaka, Eiko ^a   Kasuga, Eriko ^a   Horiuchi, Kazuki ^a   Oana, Kozue ^d,e   Kawakami, Yoshiyuki ^d,e   Honda, Takayuki ^a  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

^b KEIO UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZTREONAM; CARBENICILLIN; CEFALEXIN; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; EXTENDED SPECTRUM BETA LACTAMASE CIA 1; GENOMIC DNA; IMIPENEM; LATAMOXEF; PENICILLIN G; PIPERACILLIN; TICARCILLIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHRYSEOBACTERIUM INDOLOGENES; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHROMOSOMES, BACTERIAL; CHRYSEOBACTERIUM; CLONING, MOLECULAR; ESCHERICHIA COLI; FLAVOBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84455173132     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05165-11     Document Type: Article

References (19)

1. Akay M, Gunduz E, Gulbas Z. 2006. Catheter-related bacteremia due to Chryseobacterium indologenes in a bone marrow transplant recipient. Bone Marrow Transplant. 37:435-436. (Pubitemid 43250480)
2. Ambler RP, et al. 1991. A standard numbering scheme for the class A beta-lactamases. Biochem. J. 276:269-270.
3. Bellais S, Leotard S, Poirel L, Naas T, Nordmann P. 1999. Molecular characterization of a carbapenem-hydrolyzing beta-lactamase from Chryseobacterium (Flavobacterium) indologenes. FEMS Microbiol. Lett. 171:127-132. (Pubitemid 29094671)
4. Reference deleted.
5. Bellais S, Naas T, Nordmann P. 2002. Molecular and biochemical characterization of Ambler class A extended-spectrum beta-lactamase CGA-1 from Chryseobacterium gleum. Antimicrob. Agents Chemother. 46:966-970. (Pubitemid 34260337)
6. Bellais S, Poirel L, Leotard S, Naas T, Nordmann P. 2000. Genetic diversity of carbapenem-hydrolyzing metallo-beta-lactamases from Chryseobacterium (Flavobacterium) indologenes. Antimicrob. Agents Chemother. 44:3028-3034.
7. Bellais S, Poirel L, Naas T, Girlich D, Nordmann P. 2000. Genetic-biochemical analysis and distribution of the Ambler class A beta-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum. Antimicrob. Agents Chemother. 44:1-9. (Pubitemid 30010663)
8. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S20, vol 30, no. 1. National Committee for Clinical Laboratory Standards, Wayne, PA.
9. Guillon H, Eb F, Mammeri H. 2010. Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena. Antimicrob. Agents Chemother. 54:2231-2234.
10. Horii T, et al. 1993. Plasmid-mediated AmpC-type beta-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum beta-lactams, including moxalactam. Antimicrob. Agents Chemother. 37:984-990. (Pubitemid 23141308)
11. Hsueh PR, et al. 1997. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 16:568-574. (Pubitemid 27417320)
12. Joris B, et al. 1991. Comparison of the sequences of class A beta-lactamases and of the secondary structure elements of penicillinrecognizing proteins. Antimicrob. Agents Chemother. 35:2294-2301.
13. Lin XH, Xu YH, Cheng J, Li T, Wang ZX. 2008. Heterogeneity of bla(IND) metallo-beta-lactamase-producing Chryseobacterium indologenes isolates detected in Hefei, China. Int. J. Antimicrob. Agents 32:398-400.
14. Poirel L, et al. 1999. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene. Antimicrob. Agents Chemother. 43:573-581. (Pubitemid 29109521)
15. Ray P, Sharma K, Gautam V. 2005. Chryseobacterium indologenes bacteremia: a case report. J. Commun. Dis. 37:259-260. (Pubitemid 44670188)
16. Reynaud I, et al. 2007. A severe form of Chryseobacterium indologenes pneumonia in an immunocompetent patient. Med. Mal. Infect. 37:762-764. (Pubitemid 350122899)
17. Rossolini GM, et al. 1999. Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaA(CME)) encoding an extended-spectrum class A beta-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER beta-lactamases. Antimicrob. Agents Chemother. 43:2193-2199. (Pubitemid 29421199)
18. Silva J, et al. 2000. TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli. Antimicrob. Agents Chemother. 44:997-1003. (Pubitemid 30165282)
19. Zeba B, et al. 2009. IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso. Antimicrob. Agents Chemother. 53:4320-4326.